Cargando…
P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621541/ http://dx.doi.org/10.1097/01.HS9.0000890752.16913.40 |
_version_ | 1784821580987105280 |
---|---|
author | Lohmann, Mia Buchberger, Iris Beielstein, Anna Kaçar, Başak Mattlener, Julia Nill, Marieke Shi, Zhiyuan Heger, Jan-Michel Pallasch, Christian Ullrich, Roland Borchmann, Sven |
author_facet | Lohmann, Mia Buchberger, Iris Beielstein, Anna Kaçar, Başak Mattlener, Julia Nill, Marieke Shi, Zhiyuan Heger, Jan-Michel Pallasch, Christian Ullrich, Roland Borchmann, Sven |
author_sort | Lohmann, Mia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9621541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-96215412022-11-01 P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma Lohmann, Mia Buchberger, Iris Beielstein, Anna Kaçar, Başak Mattlener, Julia Nill, Marieke Shi, Zhiyuan Heger, Jan-Michel Pallasch, Christian Ullrich, Roland Borchmann, Sven Hemasphere Genomics, Biology & Microenvironment Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621541/ http://dx.doi.org/10.1097/01.HS9.0000890752.16913.40 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Genomics, Biology & Microenvironment Lohmann, Mia Buchberger, Iris Beielstein, Anna Kaçar, Başak Mattlener, Julia Nill, Marieke Shi, Zhiyuan Heger, Jan-Michel Pallasch, Christian Ullrich, Roland Borchmann, Sven P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma |
title | P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma |
title_full | P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma |
title_fullStr | P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma |
title_full_unstemmed | P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma |
title_short | P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma |
title_sort | p046: preclinical evaluation of novel repurposed drug combinations in hodgkin lymphoma |
topic | Genomics, Biology & Microenvironment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621541/ http://dx.doi.org/10.1097/01.HS9.0000890752.16913.40 |
work_keys_str_mv | AT lohmannmia p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma AT buchbergeriris p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma AT beielsteinanna p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma AT kacarbasak p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma AT mattlenerjulia p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma AT nillmarieke p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma AT shizhiyuan p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma AT hegerjanmichel p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma AT pallaschchristian p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma AT ullrichroland p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma AT borchmannsven p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma |